Optometrists in Norway, MI Accepting Medicare
4 Optometrists found. Showing 1 - 4
 Norway Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 525 W Highway Us 2, Norway, MI 49870 Phone: 906-563-5711 Fax: 906-563-9196 |
 Aileen N Brouwer, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 525 W Us Highway 2, Norway, MI 49870 Phone: 906-563-5711 Fax: 906-563-9196 |
 Dr. Tyler Allen Chartier, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 525 West U.s. Highway 2, Norway, MI 49870 Phone: 906-563-5711 Fax: 906-563-9196 |
Mark H Schinderle, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 525 W Us Highway 2, Norway, MI 49870 Phone: 906-563-5711 Fax: 906-563-9196 |
News Archive
New NICE-accredited guidelines on prevention and control of MDRGNB available online
Gram-negative bacteria (MDRGNB) include common types such as E. coli that all of us carry in our bowels. When these bacteria get into other parts of the body they can cause infections, including common infections such as cystitis or urinary tract infections. The bacteria can also be readily spread from person to person. Multi-drug-resistant strains are resistant to most, or all, of the common antibiotics that we use to treat infections.
VaxGen signs definitive agreement to acquire diaDexus in stock-for-stock merger
VaxGen, Inc., a biopharmaceutical company, and diaDexus, Inc., a privately held diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, announced today that they have entered into a definitive agreement under which VaxGen will acquire diaDexus in a stock-for-stock merger.
What happens in the first few days of SARS-CoV-2 infection?
New research, published in PLOS Biology, has evaluated SARS-CoV-2 infection in primary cultures of well-differentiated cells to determine how the virus affects the body and how the infection starts. Answers to these questions are essential to forming a general understanding of viral pathogenesis, which helps us develop effective prevention and treatment strategies for COVID-19.
Influenza patients treated with Tamiflu has higher survival rates
Roche announced today that two new observational studies concluded that influenza patients treated with Tamiflu(R) (oseltamivir phosphate) had significantly higher survival rates than untreated patients.
Quanterix prices public offering of common stock
Quanterix announce pricing of previously announced underwritten public offering of 2,376,238 shares of common stock public offering price of $25.25 per share.
› Verified 5 days ago
Chiropractors
Optometrists
Physical Therapists
Occupational Therapists
Audiologists